International Cholangiocarcinoma Research Network (ICRN)
The ICRN is a global collaboration of research groups from renowned institutions that are working in concert to improve knowledge about cholangiocarcinoma etiology, prevention, early detection, treatment and prognosis. The network is comprised of highly talented individuals from a spectrum of disciplines, perspectives, and research methods who share the passion to make significant scientific advances that improve outcomes for patients with cholangiocarcinoma.
The goal of ICRN is to accelerate the clinical translation of scientific discoveries to impact the lives of patients with cholangiocarcinoma.
If your industry or biotech company or organization is interested in partnering with the ICRN for the purposes of cholangiocarcinoma research and potential collaboration, please fill out the ICRN Industry Request for Engagement form.
ICRN Members Map
If you'd like more information about the ICRN, please contact Reham Abdel-Wahab.
ICRN Executive Committee
Milind Javle, MD
Chair
UT MD Anderson Cancer Center
Mitesh Borad, MD
Co-Chair
Mayo Clinic, Arizona
John Bridgewater, PhD
University College London Hospital, UK
Laura Goff, MD
Biliary Cancer Alterations Predict Therapy Choice (BATCH)
Vanderbilt Ingram Cancer Center
Lipika Goyal, MD
Genomic and Database Research WG Chair
Massachusetts General Hospital/Harvard University
Eugene J. Koay, MD, PhD
Radio-diagnostic and Radiation Oncology WG Chair
MD Anderson Cancer Center
Lawrence Kwong, PhD
Translation WG Chair
MD Anderson Cancer Center
Lewis Roberts, MB, ChB, PhD
Biorepository WG Chair
Mayo Clinic, Minnesota
Flavio Rocha, MD, FACS
Transplantation WG Chair
Virginia Mason Medical Center
Nilofer Saba Azad, M.D.
Immuno-oncology WG Chair
Johns Hopkins
Suebpong Tanasanvimon, MD
Bumrungrad International Hospital, Thailand
Advocacy Organization Hybrid Model for Advancing Research
